SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-023972
Filing Date
2020-04-08
Accepted
2020-04-08 19:53:59
Documents
1
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14744
  Complete submission text file 0001209191-20-023972.txt   16282
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1613 RAY DRIVE BURLINGAME CA 94010
Business Address
Wilson Mark Andrew (Reporting) CIK: 0001808356 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24006 | Film No.: 20782926